We aspire to be the world’s most respected and successful healthcare company – by earning and maintaining the trust of patients, associates, healthcare partners, shareholders and the society we serve.
As a global leader in healthcare, we have a responsibility to serve as a role model in how we conduct our business. We continually review and strengthen our policies and practices to meet and exceed the expectations of our stakeholders, and strive to adhere to high business, clinical and ethical standards.
Our aim is to prevent issues from occurring, drive personal accountability for behaviors, and generate learnings that can be applied across the organization.
In August 2014, we created a new position of Chief Ethics, Compliance and Policy Officer, reporting to the CEO – elevating the Compliance function to the highest levels in the company. Eric Cornut, formerly Chief Commercial Officer, Novartis Pharmaceuticals, was named to this position. His experience in our commercial organization – as well as prior positions at regional and country levels – ensure that he can help teams continue to embed a culture of high performance with integrity.
We do not tolerate unethical behavior by our associates anywhere, and we will take all necessary steps to ensure compliance with our Code of Conduct and all applicable laws. At the same time, we know there are potential pockets of bad behavior in a global business with more than 120 000 associates, and we work to take swift action when this occurs.
We have further strengthened our compliance system by adding country and global compliance risk assessments for marketing and sales. We work to identify and mitigate risk exposure proactively so it can be reviewed and discussed at a management level.
Our goal is to maintain consistent standards of business practices across Novartis, ultimately enabling us to provide the best possible care for patients globally.